Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Gadolinium-based MRI characterization of leptomeningeal inflammation in multiple sclerosis.
JC polyomavirus mutants escape antibody-mediated neutralization.
Thyroid autoimmunity and dysfunction in multiple sclerosis patients during long-term treatment with interferon beta or glatiramer acetate: an Italian multicenter study.
Teriflunomide reduces relapse-related neurological sequelae, hospitalizations and steroid use.
Long-term impact of interferon or Glatiramer acetate in multiple sclerosis: A systematic review and meta-analysis.
Clinical efficacy of BG-12 (dimethyl fumarate) in patients with relapsing-remitting multiple sclerosis: subgroup analyses of the CONFIRM study.
Association between beta-interferon exposure and hospital events in multiple sclerosis.
Repeated subcutaneous injections of IL12/23 p40 neutralising antibody, ustekinumab, in patients with relapsing-remitting multiple sclerosis: a phase II, double-blind, placebo-controlled, randomised, dose-ranging study.
Techniques and technologies for the bioanalysis of Sativex(®), metabolites and related compounds.
Activity-Dependent and Experience-Driven Myelination Provide New Directions for the Management of Multiple Sclerosis.
The mediating role of processing speed in the relationship between depressive symptoms and cognitive function in multiple sclerosis.
Decreased systemic IL-7 and soluble IL-7Rα in multiple sclerosis patients.
Teriflunomide reduces relapses with sequelae and relapses leading to hospitalizations: results from the TOWER study.
Biogen Idec receives notification of PDUFA date extension
Effects of fumarates on circulating and CNS myeloid cells in multiple sclerosis.
Epigenetics of Multiple Sclerosis: An Updated Review.
Effects of Interferon β-1a and Interferon β-1b Monotherapies on Selected Serum Cytokines and Nitrite Levels in Patients with Relapsing-Remitting Multiple Sclerosis: A 3-Year Longitudinal Study.
Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression.
A validated gene regulatory network and GWAS identifies early regulators of T cell-associated diseases.
Response to interferon-beta treatment in multiple sclerosis patients: a genome-wide association study.
Anti-inflammatory dimethylfumarate: a potential new therapy for asthma?
Persistence with and adherence to fingolimod compared with other disease-modifying therapies for the treatment of multiple sclerosis: a retrospective US claims database analysis.
Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis.
The value of qualitative and quantitative assessment of lesion to cerebral cortex signal ratio on double inversion recovery sequence in the differentiation of demyelinating plaques from non-specific T2 hyperintensities.
Contribution of different relapse phenotypes to disability in multiple sclerosis.
Pages
« first
‹ previous
…
27
28
29
30
31
32
33
34
35
…
next ›
last »